CoChat

Responses of Markers of Bone and Collagen Turnover to Exercise, Growth Hormone (GH) Administration, and GH Withdrawal in Trained Adult Males1

Wallace, Jennifer D., Cuneo, Ross C., Lundberg, Per Arne, Rosén, Thord, Jørgensen, Jens Otto Lunde, Longobardi, Salvatore, Keay, Nicola, Sacca, Luigi, Christiansen, Jens Sandahl, Bengtsson, Bengt-Åke, Sönksen, Peter H. · 2000 · The Journal of Clinical Endocrinology & Metabolism
Cited by 171

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

To examine the interactions between acute exercise and GH on markers of bone and collagen turnover and to assess the potential for detecting GH abuse in athletes using these markers, we studied 17 aerobically trained males (age, 26.9 ± 1.5 yr). Sequential studies of exercise, GH administration, and GH withdrawal were undertaken. A randomized, controlled study of rest vs. exercise showed that exercise did not change serum osteocalcin; other markers of formation increased transiently (each P < 0.001): bone-specific alkaline phosphatase (+16.1%), carboxyterminal propeptide of type I procollagen (+14.1%), and procollagen III N-terminal extension peptide (+5.0%). The carboxyterminal cross-linked telopeptide of type I collagen, a bone resorption marker, increased 9.7% (P = 0.018) in response to exercise. A randomized, double blind, placebo-controlled, parallel study of recombinant human GH treatment (0.15 IU/kg·day) for 1 week increased serum osteocalcin (net increase preexercise, +10.0%; P = 0.017), carboxyterminal propeptide of type I procollagen (+17.6%; P = 0.002), procollagen III N-terminal extension peptide (+48.4%; P = 0.001), and carboxyterminal cross-linked telopeptide of type I collagen (53.3%; P = 0.009). Disappearance half-times after cessation of recombinant human GH for pre- and postexercise markers ranged from 248–770 h. We conclude 1) endurance exercise transiently activates bone and collagen turnover; 2) brief GH administration results in similar but quantitatively greater augmentation; and 3) these data will assist in designing a GH detection strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.85.1.6262

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 57

  1. Cuneo, 1994, Growth hormone, insulin-like growth factors and sport., Endocrinol Metab, 1, 3
  2. Ohlsson, 1998, Growth hormone and bone., Endocr Rev, 19, 55
  3. Wallace, 1999, Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport., J Clin Endocrinol Metab, 84, 3591
  4. Cuneo, 1998, The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults., J Clin Endocrinol Metab, 83, 107
  5. Rickert, 1992, Human growth hormone: a new substance of abuse among adolescents?, Clin Pediatr, 31, 723, 10.1177/000992289203101206 · DOI · Paper page
  6. 1987, Acromegaly., Clin Endocrinol (Oxf), 26, 481, 10.1111/j.1365-2265.1987.tb00805.x · DOI · Paper page
  7. Brixen, 1990, A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers., J Bone Miner Res, 5, 609, 10.1002/jbmr.5650050610 · DOI · Paper page
  8. Wu, 1999, Detection of doping with human growth hormone., Lancet, 353, 895, 10.1016/S0140-6736(99)00775-8 · DOI · Paper page
  9. 1962, Methods for determining composition of the human body., Pediatrics, 29, 477, 10.1542/peds.29.3.477 · DOI · Paper page
  10. Risteli, 1993, Biochemical markers of bone metabolism., Ann Med, 25, 385, 10.3109/07853899309147301 · DOI · Paper page
  11. Stein, 1993, Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype., Endocr Rev, 14, 424, 10.1210/edrv-14-4-424 · DOI · Paper page
  12. Brixen, 1989, Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein., Calcif Tissue Int, 44, 93, 10.1007/BF02556467 · DOI
  13. Bradbeer, 1994, Fluctuation of mineral apposition rate at individual bone-remodeling sites in human iliac cancellous bone: independent correlations with osteoid width and osteoblastic alkaline phosphatase activity., J Bone Miner Res, 9, 1679, 10.1002/jbmr.5650091103 · DOI
  14. Parfitt, 1987, Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase., J Bone Miner Res, 2, 427, 10.1002/jbmr.5650020510 · DOI · Paper page
  15. Prockop, 1979, The biosynthesis of collagen and its disorders (first of two parts)., N Engl J Med, 301, 13, 10.1056/NEJM197907053010104 · DOI · Paper page
  16. Prockop, 1979, The biosynthesis of collagen and its disorders (second of two parts)., N Engl J Med, 301, 77, 10.1056/NEJM197907123010204 · DOI · Paper page
  17. Kurdy, 1998, Serology of collagen types I and III in normal healing of tibial shaft fractures., J Orthop Trauma, 12, 122, 10.1097/00005131-199802000-00010 · DOI
  18. Beaumont, 1972, Disproportional changes in haematocrit, plasma volume, and proteins during exercise and bed rest., J Appl Physiol, 33, 55, 10.1152/jappl.1972.33.1.55 · DOI · Paper page
  19. Beaumont, 1973, Changes in total plasma content of electrolytes and proteins with maximal exercise., J Appl Physiol, 34, 102, 10.1152/jappl.1973.34.1.102 · DOI · Paper page
  20. Brahm, 1997, Bone metabolism during exercise and recovery: the influence of plasma volume and physical fitness., Calcif Tissue Int, 61, 192, 10.1007/s002239900322 · DOI
  21. Brahm, 1997, 60, 175
  22. Virtanen, 1993, Effect of concentric exercise on serum muscle and collagen markers., J Appl Physiol, 75, 1272, 10.1152/jappl.1993.75.3.1272 · DOI
  23. Kristoffersson, 1995, Effects of short-term maximal work on plasma calcium, parathyroid hormone, osteocalcin and biochemical markers of collagen metabolism., Int J Sports Med, 16, 145, 10.1055/s-2007-972982 · DOI · Paper page
  24. Welsh, 1997, The acute effects of exercise on bone turnover., Int J Sports Med, 18, 247, 10.1055/s-2007-972628 · DOI · Paper page
  25. Ashizawa, 1998, Effects of a single bout of resistance exercise on calcium and bone metabolism in untrained young males., Calcif Tissue Int, 62, 104, 10.1007/s002239900402 · DOI
  26. Salvesen, 1994, Change in levels of the carboxyterminal propeptide of type I procollagen, the carboxyterminal cross-linked telopeptide of type I collagen and osteocalcin in response to exercise in well-trained men and women., Scand J Med Sci Sports, 4, 186, 10.1111/j.1600-0838.1994.tb00424.x · DOI
  27. Malm, 1993, Marathon running accompanied by transient decreases in urinary calcium and serum osteocalcin levels., Calcif Tissue Int, 52, 209, 10.1007/BF00298720 · DOI
  28. Salvesen, 1994, Intact serum parathyroid hormone levels increase during running exercise in well-trained men., Calcif Tissue Int, 54, 256, 10.1007/BF00295947 · DOI
  29. Woitge, 1998, Changes in bone turnover induced by aerobic and anaerobic exercise in young males., J Bone Miner Res, 13, 1797, 10.1359/jbmr.1998.13.12.1797 · DOI · Paper page
  30. Takala, 1986, Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in the concentration of type III procollagen aminopropeptide in human serum., Pfluegers Arch, 407, 500, 10.1007/BF00657507 · doi:10.1007/bf00657507
  31. Takala, 1989, Carbonic anhydrase III and collagen markers in serum following cross-country skiing., Med Sci Sports Exerc, 21, 593, 10.1249/00005768-198910000-00016 · doi:10.1249/00005768-198910000-00016
  32. Zanker, 1998, Bone turnover in amenorrhoeic and eumenorrhoeic women distance runners., Scand J Med Sci Sports, 8, 20, 10.1111/j.1600-0838.1998.tb00224.x · DOI · Paper page
  33. Brahm, 1997, Bone metabolism in endurance trained athletes: a comparison to population-based controls based on DXA, SXA, quantitative ultrasound, and biochemical markers., Calcif Tissue Int, 61, 448, 10.1007/s002239900366 · DOI
  34. Menkes, 1993, Strength training increases regional bone mineral density and bone remodeling in middle-aged and older men., J Appl Physiol, 74, 2478, 10.1152/jappl.1993.74.5.2478 · DOI · Paper page
  35. Casez, 1995, Bone mass at lumbar spine and tibia in young males—impact of physical fitness, exercise, and anthropometric parameters: a prospective study in a cohort of military recruits., Bone, 17, 211, 10.1016/8756-3282(95)00217-2 · DOI
  36. Lohman, 1995, Effects of resistance training on regional and total bone mineral density in premenopausal women: a randomized prospective study., J Bone Miner Res, 10, 1015, 10.1002/jbmr.5650100705 · DOI · Paper page
  37. Eliakim, 1997, Evidence for increased bone formation following a brief endurance-type training intervention in adolescent males., J Bone Miner Res, 12, 1708, 10.1359/jbmr.1997.12.10.1708 · DOI · Paper page
  38. Franck, 1991, The effect of physical activity on bone turnover in young adults., Exp Clin Endocrinol, 98, 42, 10.1055/s-0029-1211099 · DOI
  39. Whitehead, 1992, Growth hormone treatment in adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study., Clin Endocrinol (Oxf), 36, 45, 10.1111/j.1365-2265.1992.tb02901.x · DOI · Paper page
  40. Bengtsson, 1993, Treatment of adults with growth hormone (GH) deficiency with recombinant human GH., J Clin Endocrinol Metab, 76, 309
  41. Wollmann, 1995, Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency., Horm Res, 43, 249, 10.1159/000184302 · doi:10.1159/000184302
  42. Marcus, 1990, Effects of short term administration of recombinant human growth hormone to elderly people., J Clin Endocrinol Metab, 70, 519, 10.1210/jcem-70-2-519 · DOI · Paper page
  43. Holloway, 1994, Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turover in healthy elderly women., J Clin Endocrinol Metab, 79, 470
  44. Vandeweghe, 1993, Short and long-term effects of growth hormone treatment on bone turnover and mineral content in adults with growth hormone deficiency., Clin Endocrinol (Oxf), 39, 409, 10.1111/j.1365-2265.1993.tb02387.x · DOI · Paper page
  45. Balducci, 1995, Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy., Eur J Endocrinol, 132, 42, 10.1530/eje.0.1320042 · DOI
  46. Bollerslev, 1996, Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency., Eur J Endocrinol, 135, 666, 10.1530/eje.0.1350666 · doi:10.1530/eje.0.1350666
  47. Halse, 1981, Iliac crest bone mass and remodelling in acromegaly., Acta Endocrinol (Copenh), 97, 18, 10.1530/acta.0.0970018 · DOI · Paper page
  48. Ueland, 1999, Increased cortical bone content of insulin-like growth factors in acromegalic patients., J Clin Endocrinol Metab, 84, 123
  49. Bianda, 1998, Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults., J Clin Endocrinol Metab, 83, 81
  50. Brahm, 1996, Biochemical markers of bone metabolism during distance running in healthy, regularly exercising men and women., Scand J Med Sci Sports, 6, 26, 10.1111/j.1600-0838.1996.tb00066.x · DOI
  51. Schlemmer, 1997, Circadian variation in bone resorption is not related to serum cortisol., Bone, 21, 83, 10.1016/S8756-3282(97)00039-2 · DOI
  52. Woitge, 1998, Seasonal variation of biochemical indexes of bone turnover: results of a population-based study., J Clin Endocrinol Metab, 83, 68
  53. Diez, 1995, Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations., Circulation, 91, 1450, 10.1161/01.CIR.91.5.1450 · DOI · Paper page
  54. Magnusson, 1997, Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency., J Bone Miner Res, 12, 210, 10.1359/jbmr.1997.12.2.210 · DOI
  55. Verde, 1986, Serum type III procollagen propeptide levels in acromegalic patients., J Clin Endocrinol Metab, 63, 1406, 10.1210/jcem-63-6-1406 · DOI
  56. Scillitani, 1997, Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients., J Bone Miner Res, 12, 1729, 10.1359/jbmr.1997.12.10.1729 · DOI · Paper page
  57. Legovini, 1997, Long-term effects of octreotide on markers of bone metabolism in acromegaly: evidence of increased serum parathormone concentrations., J Endocrinol Invest, 20, 434, 10.1007/BF03347998 · DOI

Cited by

See all 171

Metadata

Authors
Wallace, J. D., Cuneo, R. C., Lundberg, P. A., Rosén, T., Jørgensen, J. O. L., Longobardi, S., Keay, N., Sacca, L., Christiansen, J. S., Bengtsson, B.-A., & Sönksen, P. H.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2000-01-01
Volume
85
Issue
1
Pages
124-133
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2112695616
Cited by
171
References
4
FWCI
6.13
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.